Clinical Trial: TTI-621-03

Trial Status: Open
Disease Type: Sarcoma
Trial ID TTI-621-03
Sponsor ID Trillium Therapeutics

A Phase 1/2 Study of TTI-621 in Combination with Doxorubacin in Patients with Unresectable or Metastatic High-Grade Leiomyosarcoma

1 Location

Locations

Fairfax Office

Learn More About This Trial

Other Relevant Trials
Trial ID INBRX-209
Sponsor ID Inhibrx

A Randomized, Blinded, Placebo-Controlled, Phase 2 Study of INBRX-109 in Unrsectable or Metastatic Conventional Chondrosarcoma

2 Locations
Trial ID SALA-002-EW16
Sponsor ID Salarius Pharmaceuticals

A Phase I Trial of LSD1 Inhibitor Seclidemstat (SP-2577) with and without Topetecan and Cyclophosphamide in Patients with Relapsed or Refractory Ewing Sarcoma and Select Sarcomas

1 Location